Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year, scientific institutions publish cardiovascular prevention guidelines with updated goals and recommendations based on new evidence. However, medical barriers exist that make achieving these goals difficult and gaps b...
Saved in:
| Main Authors: | Ricardo Lopez Santi, Felipe Martinez, Adrian Baranchuk, Alvaro Sosa Liprandi, Daniel Piskorz, Alberto Lorenzatti, Juan Carlos Kaski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-04-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.42 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
by: Alberto J Lorenzatti, et al.
Published: (2020-02-01) -
Assessment of the effects of methodological choice in continuity of care research: a real-world example with dyslipidaemia cohort
by: Eunyoung Choi, et al.
Published: (2021-12-01) -
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
by: Anandita Agarwala, et al.
Published: (2020-02-01) -
Rationale and Design of a Multi-National Study of Physicians’ Opinions, Attitudes, and Practices Regarding Influenza Vaccination in Patients with Cardiovascular Diseases: A Mixed Methods Designs. The FLUence Project
by: Sebastián Garcia-Zamora, et al.
Published: (2024-10-01) -
Global prevalence of dyslipidaemia in adult populations: a systematic review protocol
by: Mohamed-Syarif Mohamed-Yassin, et al.
Published: (2021-12-01)